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Loss of Very-Long O-Antigen Chains Optimizes Capsule-Mediated
Immune Evasion by Salmonella enterica Serovar Typhi
Robert W. Crawford, Tamding Wangdi, Alanna M. Spees, Mariana N. Xavier, Renée M. Tsolis, Andreas J. Bäumler
Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, California, USA
ABSTRACT Expression of capsular polysaccharides is a variable trait often associated with more-virulent forms of a bacterial spe-
cies. For example, typhoid fever is caused by the capsulated Salmonella enterica serovar Typhi, while nontyphoidal Salmonella
serovars associated with gastroenteritis are noncapsulated. Here we show that optimization of the immune evasive properties
conferred by the virulence-associated (Vi) capsular polysaccharide involved an additional alteration to the cell envelope of S.
Typhi, namely inactivation of the fepE gene, encoding the regulator of very-long O-antigen chains. Introduction of the capsule-
encoding viaB locus into the nontyphoidal S. enterica serovar Typhimurium reduced complement deposition in vitro and intes-
tinal inflammation in a mouse colitis model. However, both phenotypes were markedly enhanced when the viaB locus was intro-
duced into an S. Typhimurium fepEmutant, which lacks very-long O-antigen chains. Collectively, these data suggest that during
the evolution of the S. Typhi lineage, loss of very-long O-antigen chains by pseudogene formation was an adaptation to maxi-
mize the anti-inflammatory properties of the Vi capsular polysaccharide.
IMPORTANCE Genomic comparison illustrates that acquisition of virulence factors by horizontal gene transfer is an important
contributor to the evolution of enteric pathogens. Acquisition of complex virulence traits commonly involves horizontal trans-
fer of a large gene cluster, and integration of the gene cluster into the host genome results in the formation of a pathogenicity
island. Acquisition of the virulence-associated (Vi) capsular polysaccharide encoded by SPI7 (Salmonella pathogenicity island 7)
was accompanied in the human-adapted Salmonella enterica serovar Typhi by inactivation of the fepE gene, encoding the regula-
tor of very-long O-antigen chains. We show that the resulting loss of very-long O-antigen chains was an important mechanism
for maximizing immune evasionmediated by the Vi capsular polysaccharide. These data suggest that successful incorporation of
a capsular polysaccharide requires changes in the cell envelope of the hosting pathogen.
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Typhoid fever is a severe systemic infection that presents withfever (1) after an average incubation period of 2 weeks (2). In
contrast, gastroenteritis caused by Salmonella enterica serovar Ty-
phimurium is a localized diarrheal disease with an average incu-
bation period of24 h (3). The swift onset of diarrhea, abdominal
pain, and fever during gastroenteritis is explained by the rapid
induction of an acute inflammatory response in the intestine,
which requires deployment of two type III secretion systems
(T3SSs) encoded by Salmonella pathogenicity island 1 (SPI1) and
SPI2 (4–6). Although SPI1 and SPI2 are present in S. enterica
serovar Typhi (7), the development of intestinal inflammation is
slowed markedly during typhoid fever by expression of the
virulence-associated (Vi) capsular polysaccharide (8–10). The
anti-inflammatory properties of the Vi capsular polysaccharide
(11–13) have been proposed to contribute to the long incubation
period characteristic of typhoid fever (14, 15).
The biosynthesis of the Vi capsular polysaccharide is encoded
by the viaB locus, a 14-kb DNA region located on SPI7, a patho-
genicity island present in S. enterica serovar Typhi but absent from
Salmonella serovars associated with gastroenteritis (16, 17). The
viaB locus contains genes for the regulation (tviA), biosynthesis
(tviBCDE), and surface assembly (vexABCDE) of the Vi capsular
polysaccharide (18, 19). Expression of the positive regulator TviA
is repressed in the intestinal lumen but induced by the two-
component system EnvZ/OmpR at an osmolarity encountered in
tissue (20, 21). As a result, expression of the Vi capsular polysac-
charide is induced when bacteria transit though the intestinal ep-
ithelium (22). This regulatory mechanism ensures that S. Typhi is
encapsulated by the time it encounters complement. Expression
of the Vi capsular polysaccharide inhibits complement deposition
(23, 24), because its homopolymeric chains contain approxi-
mately 300 residues of (1,4)-2-acetamido-3-O-acetyl-2-deoxy--
D-galacturonic acid (25), a sugar that does not contain free hy-
droxyl groups available for ester formation with complement
component 3 fragment b (C3b).
Since S. Typhi is strictly human adapted, it is difficult to study
the function of its virulence factors in animal models (26). One
approach to study the role the Vi capsular polysaccharide plays in
vivo has been the introduction of the viaB locus into S. Typhimu-
rium, a natural pathogen of mice (8, 9, 12, 13, 24). However, it is
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not known whether horizontal transfer of the viaB locus is suffi-
cient to optimally deploy the encoded capsular polysaccharide for
immune evasion. Here we show that for the Vi capsular polysac-
charide to confer maximal evasion of complement fixation, it is
necessary to change the cell envelope of S. Typhimurium, a pro-
cess that also accompanied the evolution of the S. Typhi lineage.
RESULTS
Very-longO-antigen chains interferewith the functionof theVi
capsular polysaccharide in vitro.We performed an in vitro assay
to determinewhether expression of theVi capsular polysaccharide
in S. enterica serovars Typhi and Typhimurium had identical ef-
fects on inhibiting complement fixation. Consistent with previous
reports (24), analysis of bacterial cells by flow cytometry showed
that incubation of a noncapsulated S. Typhi mutant (viaB mu-
tant) in 10% human serum resulted in efficient deposition of C3b
on the bacterial surface, while complement deposition was mark-
edly reduced in the capsulated S. Typhi wild-type strain (Ty2)
(Fig. 1A and B). Similarly, a capsulated S. Typhimurium strain in
which the viaB locus of S. Typhi was inserted chromosomally into
the phoN gene (phoN::viaB mutant) deposited less complement
on its surface than the noncapsulated S. Typhimurium wild-type
strain (IR715) (Fig. 1B and C). However, the magnitude by which
expression of theVi capsular polysaccharide reduced complement
fixation was notably larger in S. Typhi than in S. Typhimurium
(Fig. 1B).
To investigate possible reasons for differences in the efficacy by
which the Vi capsular polysaccharide reduced complement depo-
sition in S. Typhi and S. Typhimurium, we compared expression
of lipopolysaccharide (LPS), a surface structure containing
O-antigen repeat units that are known to fix complement (27).
LPS molecules contain a lipid A anchor and an oligosaccharide
core but differ in the number ofO-antigen repeat units that extend
from the bacterial surface. In S. Typhimurium, O-antigen repeat
units are composed of a trisaccharide backbone, consisting of-D-
mannose-(1,4)--L-rhamnose-(1,3)--D-galactose, and a
branching sugar (abequose) that is -(1,3)-linked to D-mannose
in the backbone. Consistent with previous reports, S. Typhimu-
rium exhibited a trimodal distribution in LPS length, including
short-LPS species containing between 1 and 15 O-antigen repeat
units, long-LPS species carrying between 16 and 35 O-antigen
repeat units, and very-long-LPS species with more than 100
O-antigen repeat units (Fig. 1D) (28–30). O-antigen repeat units
of S. Typhi carry tyvelose as the branching sugar that is -(1,3)-
linked to the backbone but are otherwise identical to those of S.
Typhimurium. Interestingly, in contrast to S. Typhimurium, S.
Typhi expressed only short-LPS species and long-LPS species,
while very-long-LPS species were absent (Fig. 1D).
The fepE open reading frame encodes the length regulator of
very-long O-antigen chains (28) but is interrupted in the S. Typhi
genome by a stop codon (7). To test whether this mutation in fepE
is responsible for the lack of LPS species with very-long O-antigen
FIG 1 (A to C) Fixation of C3 after incubation of the indicated S. Typhi and S. Typhimurium strains (wild type andmutants) in 10%human serumwas detected
by flow cytometry using an anti-human C3 (-human C3) FITC conjugate. The experiments shown in panels A and Cwere repeated 3 times independently with
similar outcomes, and a representative example is shown. The average maximum fluorescence intensity (MFI) values standard errors (error bars) determined
for these three independent experiments are shown in panel B. (D) Silver-stained SDS-PAGE of LPS preparations from the indicated S. Typhimurium and S.
Typhi strains. The positions of short, long, and very-long O-antigen chains are indicated to the left of the gel. A magnification of the region showing long and
very-long O-antigen chains is shown on the right, and the presence of very-long O-antigen chains in S. Typhimurium strains is indicated by black arrows.
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chains in S. Typhi, we introduced a plasmid carrying the cloned S.
Typhimurium fepE gene (pRC37). In contrast to the wild-type S.
Typhi, an S. Typhi strain carrying a plasmid encoding the S. Ty-
phimurium fepE gene (pRC37) produced LPS species with very-
long O-antigen chains (Fig. 2A). These data suggested that con-
version of fepE into a pseudogene was responsible for the inability
of S. Typhi to produce very-long O-antigen chains, which con-
firmed previous results (31).
We reasoned that very-long O-antigen chains containing an
estimated 100 copies of a repeat unit composed of a trisaccharide
backbone (28) might rival in length the homopolymeric chains of
the Vi capsular polysaccharide comprising approximately 300
sugar residues (25). Therefore, we wanted to test whether the re-
duced efficacy by which the Vi capsular polysaccharide dimin-
ished complement deposition in S. Typhimurium was due to the
presence of very-long O-antigen chains. A mutation in fepE was
introduced into the wild-type S. Typhimurium and an S. Typhi-
murium phoN::viaBmutant. Analysis by flow cytometry revealed
similar expression levels of the Vi capsular polysaccharide in S.
Typhi (Ty2), the S. Typhimurium fepE phoN::viaB mutant
(RC60), and the S. Typhimurium phoN::viaB mutant (TH170),
while capsule expression was absent in the wild-type S. Typhimu-
rium (IR715), the S. Typhimurium fepEmutant (RC31), and the
S. Typhi viaB mutant (STY2) (Fig. 2B). Expression of very-long
O-antigen chains was abrogated in the fepE mutant (Fig. 2A).
Furthermore, expression of very-long O-antigen chains could be
restored in the fepE mutant by introducing the fepE gene cloned
on a plasmid (pRC37). Remarkably, complement fixation was
markedly reduced in the S. Typhimurium fepE phoN::viaBmutant
compared to the S. Typhimurium phoN::viaB mutant (Fig. 2C).
These data suggested that very-long O-antigen chains impaired
the ability of the Vi capsular polysaccharide to prevent comple-
ment deposition on the surface of S. Typhimurium.
Lack of very-long O-antigen chains enhances capsule-
mediated suppressionof colitis.Weused themouse colitismodel
(5) to investigate the biological relevance of our observations. In
this model, mice are preconditioned by treatment with strepto-
mycin, which disrupts the resident microbiota. Subsequent inoc-
ulation with S. Typhimurium results in acute cecal inflammation,
which is an animal model for human gastroenteritis (reviewed in
reference 26). Groups of streptomycin-pretreated mice were ei-
ther mock infected or inoculated with the wild-type S. Typhimu-
rium or a fepE mutant, phoN::viaB mutant, or fepE phoN::viaB
mutant, and the cecum and colon contents were collected 72 h
after infection. While the wild-type S. Typhimurium and phoN::
viaB mutant were recovered in similar numbers from cecal con-
tents, a small but significant (P  0.05) reduction in bacterial
numbers was observed for strains lacking very-long O-antigen
chains (i.e., the fepE mutant and fepE phoN::viaB mutant)
(Fig. 3A). These data were consistent with our previous observa-
FIG 2 (A) Silver-stained SDS-PAGE of LPS preparations from the indicated S. Typhimurium and S. Typhi strains (wild type and mutants). Plasmid pRC37
carries the cloned S. Typhimurium fepE gene. The positions of very-long O-antigen chains are indicated by black arrows. (B) Vi capsular polysaccharide
expression was detected by flow cytometry. Cells of the indicated S. Typhi and S. Typhimurium strains were labeled with rabbit anti-Vi serum/goat anti-rabbit
FITC conjugate (-Vi on the y axis), and fluorescence intensities were determined for 10,000 particles. Each experiment was repeated 3 times independently with
similar outcomes, and a representative example is shown. (C) Fixation ofC3 after incubation of the indicated S. Typhi and S. Typhimurium strains in 10%human
serumwas detected by flow cytometry using an anti-humanC3 FITC conjugate. The experiment was repeated 3 times independently with similar outcomes, and
a representative example is shown.
O Antigen Impairs Function of Capsule
July/August 2013 Volume 4 Issue 4 e00232-13 ® mbio.asm.org 3
tion that very-longO-antigen chains are required for optimal sur-
vival of S. Typhimurium in the lumen of the inflamed gut (32).
To assess how the presence of very-long O-antigen chains in-
fluences inflammatory responses in the cecal mucosa, we deter-
mined mRNA levels of inflammatory markers, including gamma
interferon (IFN-) encoded by the Infg gene, tumor necrosis fac-
tor alpha (TNF-) encoded by the Tnfa gene, interleukin-22 (IL-
22) encoded by the Il22 gene, keratinocyte-derived cytokine (KC)
encoded by the Kc gene, and macrophage-inducible protein 2
(MIP-2) encoded by the Mip2 gene, by quantitative real-time
PCR. Although the wild-type S. Typhimurium was recovered in
significantly greater numbers from colon contents than the fepE
mutant (Fig. 3A), both strains elicited similar levels of Ifng, Tnfa,
Il22, Kc, and Mip2 expression in the cecal mucosa (Fig. 3B to F).
Thus, the presence of very-long O-antigen chains did not alter
expression levels of inflammatorymarkers elicited by S. Typhimu-
rium in themouse colitismodel. Introduction of the S. Typhi viaB
locus into the S. Typhimurium genome (phoN::viaBmutant) sig-
nificantly (P 0.05) reduced mRNA levels of Ifng, Tnfa, Il22, Kc,
and Mip2 compared to those elicited by infection with the wild-
type S. Typhimurium (Fig. 3B to F). These data were consistent
with our previous observation that expression of the Vi capsular
polysaccharide in S. Typhimurium reduces intestinal inflamma-
tory responses in the mouse colitis model (9). Remarkably, intro-
duction of the viaB locus into the fepE mutant (fepE phoN::viaB
mutant) significantly (P  0.05) reduced mRNA levels of Ifng,
Tnfa, Il22, Kc, and Mip2 compared to those elicited by infection
with the phoN::viaBmutant (Fig. 3B to F). Thus, in the absence of
very-long O-antigen chains, the viaB locus suppressed expression
of inflammatory markers to a significantly (P 0.05) greater ex-
tent than in their presence. Reduced expression of inflammatory
markerswas independent of the bacterial burden, because the fepE
mutant and the fepE phoN::viaBmutant were recovered in similar
numbers (Fig. 3A), whereas the former elicited significantly (P
0.05) highermRNA levels of Ifng,Tnfa, Il22,Kc, andMip2 than the
latter (Fig. 3B to F).
We next performed a blinded analysis of histopathological
changes observed in the cecal mucosa 72 h after infection to de-
termine the biological consequences of expressing very-long
O-antigen chains and/or the Vi capsular polysaccharide. Ceca
from mice infected with the wild-type S. Typhimurium or a fepE
mutant were devoid of any contents and had severe gross patho-
logical changes, characterized by reduced size with thickening of
the cecal wall. Histopathological evaluation revealed epithelial
erosion, neutrophil infiltration in the mucosa, and edema in the
submucosa. In contrast, ceca from mock-infected mice did not
show gross pathological changes or overt histopathology (Fig. 4).
Introduction of the S. Typhi viaB locus into the S. Typhimurium
genome (phoN::viaBmutant) resulted in a small but significant (P
 0.05) reduction in the severity of histopathological changes
compared tomice infected with the wild-type S. Typhimurium or
a fepEmutant. Remarkably, infection with a fepE phoN::viaBmu-
FIG 3 Streptomycin-pretreated mice were infected with the indicated S. Typhimurium strains, and the cecum and colon contents were collected 72 h after
infection. (A) Recovery of S. Typhimurium from colon contents. Values are geometric means of CFU per gram colon contents standard errors (error bars). (B
to F) Transcript levels of Ifng (B), Tnfa (C), Il22 (D), Kc (E), and Mip2 (F) in the cecal mucosa were determined by quantitative real-time PCR. Values are
geometric means standard errors of fold increases overmRNA levels inmock-infected animals. Values that are statistically significant (P 0.05) are indicated
by a bar and asterisk. Values that are not statistically significant (ns) are indicated.
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tant resulted in a significant (P 0.05) reduction in the severity of
histopathological changes compared to the phoN::viaB mutant.
Overall, the results from this histopathological analysis (Fig. 4)
substantiated results from expression analysis of inflammatory
markers in the cecal mucosa (Fig. 3B to F) and supported the
concept that optimal suppression of intestinal inflammation by
the viaB locus requires an absence of very-long O-antigen chains.
DISCUSSION
The fact that the vast majority of the 2,587 known serovars of
S. enterica are zoonotic and associated with a localized, self-
limiting gastroenteritis in immune-competent individuals (33)
suggests that human-restricted specialists associated with sys-
temic febrile illnesses, such as S. enterica serovar Typhi or Paraty-
phi A, evolved from ancestral zoonotic organisms that caused gas-
troenteritis (34). While the S. enterica species is estimated to be 40
to 63 million years old (35), S. Typhi represents a clonal lineage
that emerged only recently, between 10,000 and 150,000 years ago
(36, 37). After the S. Typhi lineage had passed through approxi-
mately 75% of its evolutionary history, it exchanged some 23% of
its genome by horizontal gene transfer with the S. Paratyphi A
lineage, presumably during coexistence in a shared human reser-
voir (38). Subsequent to this large-scale genetic exchange, which
might mark the origin of typhoid and paratyphoid fever, the lin-
eages of S. Typhi and S. Paratyphi A became isolated again, and
both of their genomes subsequently accumulated pseudogenes at
an accelerated rate (39).
Many pseudogenes present in S. Typhi encode functions re-
quired for the gastrointestinal lifestyle of S. Typhimurium. For
example, the genome of S. Typhi strain CT18 contains pseudo-
genes in 7 of its 11 chaperone/usher-type fimbrial operons (40),
which encode adhesins required by S. Typhimurium to colonize
the intestinal lumen (41). Furthermore, the S. Typhi genome car-
ries pseudogenes in operons functioning in anaerobic respiration
(ttrS, dmsA, dmsB, narV, and narW) (7, 42), and these functions
are required by S. Typhimurium to outgrow obligate anaerobic
bacteria in the lumen of an acutely inflamed gut during gastroen-
teritis (43, 44). While these genes are likely maintained in S. Ty-
phimurium because they aid in intestinal growth and transmis-
sion during gastroenteritis (45), they can be seen as dispensable
for the extraintestinal lifestyle of S. Typhi, a pathogen that spreads
by means of water, milk, and food products contaminated by in-
dividuals with chronic gallbladder carriage (46). Thus, pseudo-
gene formation in S. Typhi is commonly viewed as a process lead-
ing to random losses of genetic functions that are inherited from
an ancestral organism associated with gastroenteritis but that are
not required for causing typhoid fever in humans.
Our results suggest that, surprisingly, the formation of one
pseudogene, namely, a fepE allele interrupted by a stop codon,
resulted in a gain of function during the evolution of the S. Typhi
lineage. Specifically, we show that inactivation of fepE resulted in
an enhanced functionality of the Vi capsular polysaccharide. The
Vi capsular polysaccharide is an important virulence factor of S.
Typhi (reviewed in reference 47) and has been developed into a
vaccine against typhoid fever (48). Expression of the Vi capsular
polysaccharide inhibits complement deposition (23, 24), a process
that was more efficient in strains lacking a functional fepE gene.
One consequence of complement activation is the formation of a
membrane attack complex on the bacterial surface that leads to
lysis unless serum resistancemechanisms are deployed. One study
reports that the Vi capsular antigen is not required for serum
resistance of S. Typhi (31), but in this study, bacteria were grown
in Luria-Bertani (LB) broth, a condition that represses expression
of the Vi capsular polysaccharide (20, 21). In several other studies,
expression of the Vi capsular polysaccharide was shown to in-
crease serum resistance of S. Typhi (23, 24, 49), which is consistent
with its role in preventing complement deposition (Fig. 1A).
A second consequence of complement deposition and activa-
tion of the alternative pathway is the production of anaphylatox-
ins (C3a and C5a). Anaphylatoxins are potent enhancers of cyto-
kine responses elicited by stimulating the Toll-like receptor 4
(TLR4)/MD2/CD14 receptor complex with LPS (reviewed in ref-
erence 50). Thus, suppression of complement activation by the Vi
capsular polysaccharide might explain why expression of this vir-
ulence factor diminishes the induction of TLR4/MD2/CD14-
dependent proinflammatory responses (10–13). Expression of the
Vi capsular polysaccharide in S. Typhimurium attenuates intesti-
nal inflammation elicited in bovine ligated ileal loops (8) and in
FIG 4 Streptomycin-pretreated mice were either mock infected or infected with the indicated S. Typhimurium strains, and the cecum was collected 72 h after
infection. (A) Combined histopathology score of pathological changes observed in sections from the cecum. Each symbol represents the combined histopathol-
ogy score for an individual animal. The average for each group of mice is indicated by a short line. (B) Representative images of histopathological changes.
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the mouse colitis model (9). Interestingly, suppression of intesti-
nal inflammation by the Vi capsular polysaccharide was signifi-
cantly enhanced when production of very-long O-antigen chains
was abrogated by inactivation of the fepE gene. These data suggest
that conversion of fepE into a pseudogene enhanced the ability of
S. Typhi to suppress or delay intestinal inflammation using the Vi
capsular polysaccharide.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. Bacterial strains
used in this study are presented in Table 1. A plasmid carrying the S. en-
terica serovar Typhimurium fepE gene cloned into the low-copy-number
vector pWSK129 has been described previously (32). Bacterial cultures
were routinely incubated with aeration at 37°C in Luria-Bertani (LB)
broth (10 g tryptone, 5 g yeast extract, and 10 g NaCl per liter) or on LB
agar plates (15 g agar per liter) unless capsule expression was desired. To
induce expression of the Vi capsular polysaccharide, bacteria were grown
in broth containing 10 g tryptone and 5 g yeast extract per liter. The
following antibiotics were added as necessary at appropriate concentra-
tions: chloramphenicol (Cm), 0.03mg/ml; carbenicillin, 0.1mg/ml; kana-
mycin (Kan), 0.05 mg/ml; and nalidixic acid, 0.05 mg/ml.
Construction of mutants. The fepE::pGP704 mutation was trans-
duced from S. Typhimurium RC31 into the S. Typhimurium phoN::viaB
mutant TH170 using transduction with phage P22 HT int-105 to yield
strain RC60.
Animal experiments. All animal experiments were approved by the
Institutional Animal Care andUse Committee (IACUC) at the University
of California, Davis, and performed according to Association for Assess-
ment and Accreditation of Laboratory Animal Care (AAALAC) guide-
lines. Groups (n 4) of female mice (C57BL/6J mice from Jackson Lab-
oratory) aged 6 to 8 weeks were inoculated intragastrically with 20 mg
streptomycin in a volume of 0.1 ml 24 h prior to intragastric inoculation
with either 0.1 ml sterile LB broth or 1  109 CFU of the indicated S.
Typhimurium strains. Colon contents and cecal tissues were harvested at
72 or 120 h after infection, homogenized in phosphate-buffered saline
(PBS), serially diluted, and plated on LB agar plates containing the appro-
priate antibiotics to enumerate CFU.
RNA extraction and quantitative real-time PCR. Cecal tissue was
homogenized in a minibeadbeater (BioSpec Products), and RNA was ex-
tracted by the TRI reagent method (Molecular Research Center) as de-
scribed previously (51). Reverse transcription was performed using Taq-
Man reagent (Applied Biosystems), and 2l of converted cDNAwas used
with a 250 nM concentration of primers listed in Table 2 and SYBR green
(Applied Biosystems) for real-time PCR in the ViiA 7 system (Life Tech-
nologies). Data were analyzed using the comparative threshold cycle
method. Transcription levels of Ifng, Tnfa, IL22, Kc, andMip2 genes were
normalized to GapdhmRNA (encoding glyceraldehyde-3-phosphate de-
hydrogenase [GAPDH]).
Histopathology. Cecal tissues were formalin fixed, sectioned, stained
with hematoxylin and eosin (H&E) and submitted to a veterinary pathol-
ogist for blinded scoring using a scale described previously (52). Repre-
sentative images of tissue sections were taken using an Olympus BX41
microscope.
Analysis ofVi andLPS expression andC3deposition byflowcytom-
etry. Detection of Vi and LPS expression by flow cytometry was per-
formed as described previously (9) using the DNA-specific stain pro-
pidium iodide, rabbit anti-Vi serum, or anti-O:4 (1:250 dilution; Becton
Dickinson) and goat anti-rabbit fluorescein isothiocyanate (FITC) con-
jugate (1:250 dilution; Jackson ImmunoResearch). Binding of comple-
ment component 3 (C3) was determined by flow cytometry as described
previously (24) using the DNA-specific stain propidium iodide, human
serum (10% dilution; Quidel), and fluorescein isothiocyanate (FITC)-
conjugated goat anti-human C3b monoclonal antibody (1:250 dilution;
MP Biomedicals). All samples were analyzed on an LSRII instrument
(BD).
Statistical analysis. Relative abundance values of S. Typhimurium
strains and fold changes in mRNA levels were converted logarithmically
(log10) prior to statistical analysis using a one-tailed parametric test (Stu-
dent’s t test. A P value of0.05 was considered to be significant.
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S. Typhimurium
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RC31 IR715 fepE::pGP704 32
TH170 IR715 phoN::viaB 9
RC60 IR715 phoN::viaB fepE::pGP704 This study
S. Typhi
strains
Ty2 Wild-type strain; ATCC 700931
STY2 Ty2 viaB::Kan 10
TABLE 2 Nucleotide primers for quantitative real-time PCR
Target gene Nucleotide sequence
Gapdh 5=-TGTAGACCATGTAGTTGAGGTCA-3=
5=-AGGTCGGTGTGAACGGATTTG-3=
Ifng 5=-TCAAGTGGCATAGATGTGGAAGAA-3=
5=-TGGCTCTGCAGGATTTTCATG-3=
Tnfa 5=-TTGGGTCTTGTTCACTCCACGG-3=
5=-CCTCTTTCAGGTCACTTTGGTAGG-3=
IL22 5=-GGCCAGCCTTGCAGATAACA-3=
5=-GCTGATGTGACAGGAGCTGA-3=
Kc 5=-TGCACCCAAACCGAAGTCAT-3=
5=-TTGTCAGAAGCCAGCGTTCAC-3=
Mip2 5=-AGTGAACTGCGCTGTCAATGC-3=
5=-AGGCAAACTTTTTGACCGCC-3=
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